Corgi NVO 2x Daily ETF is a U.S.-domiciled exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to twice the daily performance of the publicly traded common shares of Novo Nordisk A/S (NYSE: NVO). The fund is managed by Corgi Strategies, LLC and is offered through Corgi ETF Trust I. NVOC provides leveraged, single-stock exposure to Novo Nordisk through financial instruments, principally swap agreements and potentially exchange-traded equity futures, rather than by seeking to replicate a long-term two-times return. Its portfolio may also include cash, cash equivalents, U.S. Treasury bills and other collateral or financing instruments used in support of its derivatives strategy; the fund resets its leverage exposure each trading day and is intended primarily for investors seeking tactical, short-term exposure to daily movements in Novo Nordisk shares. The ETF trades on Cboe BZX Exchange, Inc. under the ticker symbol NVOC and carries a 0.45% expense ratio. Corgi NVO 2x Daily ETF launched on July 14, 2026, representing Corgi Strategies’ expansion of its leveraged single-stock ETF lineup; the launch introduced a dedicated 2x daily Novo Nordisk product to the U.S. exchange-traded-fund market. As of September 8, 2026, the fund reported net asset value of $20.56 and assets under management of approximately $308,000. Corgi Strategies, LLC is headquartered in the United States.